ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,572.85
      0.10%
      US Tech 100
      19,967.60
      0.37%
      Dow Jones
      39,344.79
      -0.08%
      Brent Oil
      85.195
      -0.26%
      Bitcoin
      57,495.69
      1.39%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Medicines Company (MDCO)

      7. Medicines Company (MDCO) News

      MDCO

      Medicines (MDCO)

      Medicines Company
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MDCO
      DateTimeSourceHeadlineSymbolCompany
      11/26/20195:26PMPR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates The Medicines Co.NASDAQ:MDCOMedicines Company
      11/26/20194:34PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:MDCOMedicines Company
      11/25/20194:54PMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:MDCOMedicines Company
      11/25/20192:21PMPR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of The Medicines CompanyNASDAQ:MDCOMedicines Company
      11/25/201910:09AMDow Jones NewsThe Medicines Co. Shares Up 23% on Novartis Buyout OfferNASDAQ:MDCOMedicines Company
      11/25/20198:41AMPR Newswire (US)(MDCO) Alert: Johnson Fistel Investigates Proposed Sale of The Medicines Company; Is $85 a Fair Price?NASDAQ:MDCOMedicines Company
      11/25/20197:33AMEdgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:MDCOMedicines Company
      11/25/20196:39AMEdgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:MDCOMedicines Company
      11/25/20196:36AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MDCOMedicines Company
      11/25/20193:02AMDow Jones NewsNovartis Expands Its Push Into Heart Drugs -- WSJNASDAQ:MDCOMedicines Company
      11/24/20196:34PMDow Jones NewsNovartis to Buy Drugmaker The Medicines Co. --2nd UpdateNASDAQ:MDCOMedicines Company
      11/24/20193:05PMBusiness WireThe Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 BillionNASDAQ:MDCOMedicines Company
      11/19/201911:16AMDow Jones NewsMedicines Co. Shares Up 19% After Bloomberg ReportNASDAQ:MDCOMedicines Company
      11/19/20198:57AMDow Jones NewsMedicines Co. Shares Up 26% After Bloomberg ReportNASDAQ:MDCOMedicines Company
      11/18/20199:00AMBusiness WireThe Medicines Company Announces that the ORION-9 Study of Inclisiran in HeFH Patients Showed Durable & Potent LDL-C Lowering ...NASDAQ:MDCOMedicines Company
      11/16/201910:45AMBusiness WireThe Medicines Company Announces that the ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable & Potent Lowering of L...NASDAQ:MDCOMedicines Company
      11/06/20194:30PMBusiness WireThe Medicines Company to Present Inclisiran Data from ORION-9 & ORION-10 Pivotal Phase 3 Clinical Studies at American Heart A...NASDAQ:MDCOMedicines Company
      10/30/20194:52PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MDCOMedicines Company
      10/30/20197:19AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MDCOMedicines Company
      10/30/20197:00AMBusiness WireThe Medicines Company Reports Third-Quarter 2019 Financial Results and Achievement of Major Milestones for InclisiranNASDAQ:MDCOMedicines Company
      10/24/20194:30PMBusiness WireThe Medicines Company to Announce Third Quarter 2019 Financial Results on October 30NASDAQ:MDCOMedicines Company
      10/04/201911:00AMBusiness WireThe Medicines Company to Participate in the Chardan 3rd Annual Genetic Medicines ConferenceNASDAQ:MDCOMedicines Company
      09/25/20197:05AMBusiness WireThe Medicines Company Announces Positive Topline Results for ORION-10 Phase 3 Study of Inclisiran in ASCVD PatientsNASDAQ:MDCOMedicines Company
      09/25/20197:00AMBusiness WireThe Medicines Company Announces Positive Topline Results for ORION-9 Phase 3 Study of Inclisiran in Heterozygous Familial Hyp...NASDAQ:MDCOMedicines Company
      09/04/20194:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
      09/04/20194:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
      09/04/20194:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
      09/04/20194:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MDCOMedicines Company
      09/02/20192:30AMBusiness WireThe Medicines Company Presents Results from ORION-11, First Phase 3 Trial of Inclisiran, Showing Durable & Potent Lowering of...NASDAQ:MDCOMedicines Company
      08/26/20197:00AMBusiness WireThe Medicines Company Announces Positive Topline Results from First Pivotal Phase 3 Trial of InclisiranNASDAQ:MDCOMedicines Company
       Showing the most relevant articles for your search:NASDAQ:MDCO